Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cyclin D1 (CCND1) (Middle Region) Peptide

CCND1 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN974599

Aperçu rapide pour Cyclin D1 (CCND1) (Middle Region) Peptide (ABIN974599)

Antigène

Cyclin D1 (CCND1)

Origine

Humain

Source

  • 14
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-CCND1 antibody (Catalog #: AVARP03037_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    Cyclin D1 (CCND1)

    Sujet

    CCND1 belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis.The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: BCL1, D11S287E, PRAD1, U21B31

    Protein Interaction Partner: CHUK,CREBBP,CTNNB1,ERCC3,ESR1,NCOA3,POLR2A,RELA,BRCA1,CDK4,CDK4,CDK6,CDKN1A,CDKN1A,CDKN1A,CDKN1B,KLF6,PIN1,RB1,TAF1,FOXO4,AKAP8,AR,BRCA1,CALM1,CCNDBP1,CDK4,CDK6,CDKN1A,CDKN1B,CTNNB1,CUL3,DMTF1,EP300,ESR1,GSK3B,HDAC3,HERC5,IFI27,INSM1,KAT2B,MCM10,MYBL2,NCOA1,NCOA3,NPDC1,ORC4L,PCNA,PRKACA,RB1,RBL1,RBL2,RBX1,RFC1,RUNX1,SP1,STAT3,TAF1,THRA,THRB,TSC2,CREB1,EGFR,STAT3,AKAP8,AR,BRCA1,CCNDBP1,CDK4,CDK6,CDKN1A,CDKN1B,CDKN1C,CDKN2A,EP300,ESR1,HDAC3,HERC5,KAT2B,Mybl2,NCOA1,NCOA3,NEUROD1,NPDC1,PCNA,RB1,RBX1,RFC1,STAT3,TAF1,THRA,THRB,TSC2,XPO1

    Protein Size: 295

    Poids moléculaire

    34 kDa

    ID gène

    595

    NCBI Accession

    NM_053056, NP_444284

    UniProt

    P24385
Vous êtes ici:
Chat with us!